Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
NKGen Biotech, Inc. (NKGN) had Weighted-Average Shares Outstanding (Diluted) of 102.66M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$15.35M |
|
-- |
|
-- |
|
$4.67M |
|
$-4.67M |
|
$20.02M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
$-4.67M |
|
$-4.29M |
|
45.96M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
102.66M |
$0.33 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$2.38M |
|
$13.02M |
|
$13.46M |
|
$15.84M |
|
$43.89M |
|
$11.08M |
|
$22.29M |
|
$66.17M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
51.31M |
|
| Cash Flow Statement Financials | |
$-2.80M |
|
$-0.05M |
|
$2.65M |
|
$0.23M |
|
$0.03M |
|
$-0.21M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-0.28 |
|
-0.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.50% |
|
-30.50% |
|
96.89% |
|
-39.10% |
|
$-0.98 |
|
$-0.03 |
|
$-0.03 |
|